Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,435 public trials 3,300 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

NCT07291076

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Local Institution - 0137 Duarte, California, United States
  • Local Institution - 0070 Los Angeles, California, United States
  • Local Institution - 0107 Chicago, Illinois, United States
  • Local Institution - 0134 Detroit, Michigan, United States
View all 67 locations
View Trial Details
Recruiting

Evaluating Novel Therapies in ctDNA Positive GI Cancers

NCT05482516

Conditions
Adenocarcinoma, Adenocarcinoma of Biliary Tract, Carcinoma, +24 more
Locations
  • Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
  • Medstar Washington Hospital Center Washington D.C., District of Columbia, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Recruiting

Evaluation of Seismocardiography(SCG) for Assessing Fitness and Predicting Outcomes in Oesophageal Cancer Surgery

NCT07159711

Conditions
Adenocarcinoma Of Esophagus, Digestive System Diseases, Digestive System Neoplasms, +12 more
Locations
  • Royal Surrey NHS Foundation Trust Guildford, United Kingdom
  • Guy's and St Thomas' Hospital NHS Foundation Trust London, United Kingdom
  • Royal Marsden NHS Foundation Trust London, United Kingdom
  • University Hospital Southampton Southampton, United Kingdom
View Trial Details
Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

NCT06997497

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +12 more
Locations
  • Los Angeles Hematology Oncology Medical Group ( Site 0084) Los Angeles, California, United States
  • Orlando Health Cancer Institute ( Site 0065) Orlando, Florida, United States
  • University of Iowa ( Site 0074) Iowa City, Iowa, United States
  • University of Kentucky ( Site 0055) Lexington, Kentucky, United States
View all 236 locations
View Trial Details
Recruiting

Rollover Study for Participants Who Have Been Treated With and Are Continuing to Benefit From Opnurasib as a Single Agent or in Combination With Other Study Treatments

NCT07468071

Conditions
Advanced Solid Tumors Harboring the KRAS G12C Mutation, Bronchial Neoplasms, Carcinoma, Bronchogenic, +18 more
Locations
  • Novartis Investigative Site Sint-Niklaas, Oost Vlaanderen, Belgium
  • Novartis Investigative Site Montreal, Quebec, Canada
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Koto Ku, Tokyo, Japan
View all 17 locations
View Trial Details

Related conditions